Stay updated on Risankizumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov record for the risankizumab atopic dermatitis study is available, with details on its design, participants, treatment arms, and outcome measures. It also includes results-related information, study locations, and links to supporting documents and data-sharing resources.
    Difference
    100%
    Check dated 2026-11-08T06:10:17.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T03:51:55.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T04:25:32.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T03:49:46.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T04:50:37.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the previous content that presented the trial's details. This results in the trial information being inaccessible from the page.
    Difference
    21%
    Check dated 2026-09-20T02:54:16.000Z thumbnail image

Stay in the know with updates to Risankizumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.